Janssen-Cilag International NV announced that the Committee for Human Medicinal Products (CHMP) in the European U nion, has granted a positive opinion recommending approval of INVEGA? (paliperidone prolonged release tablets). INVEGA? is a new, once-daily, prolonged release oral medication, for the treatment of schizophrenia.
Biomedical researchers have identified a cellular protein that interferes with hepatitis C virus replication, a finding that ultimately may help scientists develop new drugs to fight the virus.
Professor Alison Jones said benzylpiperazine was a ?new drug of abuse? which could have seriousclinical effects – similar to those of ecstasy to which it is structurally related.
Every year, at least 200 000 people die from cancer related to their workplace, according to the World Health Organization (WHO). Saturday is World Day for Safety and Health at Work.
The clinical outcomes of the JIKEI HEART Study, the large-scale clinical trial headed by the Jikei University School of Medicine, was today published in the internationally renowned medical journal The Lancet.
An anti-reflux valve developed to help esophageal cancer patients also has been shown to help those with bile duct obstruction, according to Kulwinder S. Dua, M.D., a research physician at the Medical College of Wisconsin in Milwaukee.
The amount Americans spent on arthritis medications more than doubled between 1998 and 2003, due to the fast-rising number of people with the disease, increases in the number of medications they take each month and the inflation-adjusted cost per prescription, according to a new study led by a UCSF researcher.
The herbal medicine Dan Shen, a standard treatment for ischemic stroke in China, lacks strong scientific evidence to support such use, according a new review of studies.
A new study shows that aspirin therapy for coronary artery disease is four times more likely to be ineffective in women compared to men with the same medical history.
Preservation of an organ intended for transplant during transport from donor to recipient is of primary concern in ensuring a successful transplant. Research presented at the ISHLT 27th Annual Meeting and Scientific Sessions today explores two diverging systems for pump preservation — the Organ Care System and the cold preservation method, and how they each effect survival for heart transplant patients.